Background. Despite a recent increased awareness of the need for quality End of Life (EOL) care for patients with advanced kidney disease, there is no established method for measuring or auditing outcomes relating to EOL care in this population. Methods. We designed a one-page proforma, which was used to collect data on various aspects of EOL care relating to all deaths of patients on dialysis and patients dying on specialist renal wards, over a predefined 8-week period in 10 hospitals in London and South-East England. Results. One hundred and thirty-eight deaths were recorded over the 8-week study period. The majority of patients (83%) were receiving maintenance haemodialysis prior to their terminal presentation. About 69% of deaths occurred during an in-patient hospital admission-of these, 36% were considered 'unexpected' and most quality markers of good EOL management were significantly less likely to be achieved in these patients, including use of palliative care strategies, good symptom control and overall quality of death. Thirty-six per cent of patients were from various ethnic minorities, and in this group, there was a trend towards lower use of palliative care pathways and lower rates of withdrawal from dialysis. Conclusions. This study confirms that it is possible to measure many important outcomes relating to quality of EOL care using a proforma completed at the time of death. Our findings suggest that many aspects of good EOL care are under-achieved in our region. This, in part, is due to a failure to recognize the worsening trajectory of the deteriorating patient, resulting in missed opportunities for EOL care planning and appropriate symptom control. Our observations suggest that there is a need for improved education and training in this area, particularly in detection of the dying patient, the value of advance care planning and the utility of tools such as the Liverpool Care Pathway.
Introduction
Recent years have seen an increasingly aged population with advanced renal disease who demonstrate significant co-morbidities, a substantial symptom burden and poor survival [1] . Consequently, the need for quality End of Life (EOL) care that attends to the specific needs of this population has been recognized [2] . A decade ago, the Renal Physicians Association (RPA) and the American Society of Nephrology published a clinical practice guideline that emphasized the importance of shared decision making, informed consent and palliative care for patients with advanced renal disease [3] . More recent publications, including an update of the RPA guideline in the USA [4] and recommendations issued by the Department of Health (DOH) in the UK [5] have reiterated the importance of providing quality EOL care in this population. Each of these documents describe several common features of good quality EOL care, including recognition of the dying patient, communication with patients and carers regarding prognosis and desired level of care, symptom control and enabling preferred place of care. The UK DOH document states that the 'characteristics of care during the last days of life which have consistently been found to be important from the patient's perspective are adequate pain and symptom management, avoiding inappropriate prolongation of dying, achieving a sense of control, relieving burden on loved ones and strengthening relationships with loved ones', based on the previous observations of Singer et al. [6] .
Despite these recommendations and increased awareness of the need for good EOL care, there is limited data on measuring the quality of dying in the advanced renal disease population. In 2000, Cohen et al. developed the Dialysis Discontinuation Quality of Dying (DDQOD) tool, a scoring system to distinguish between good and bad deaths and in a multicentre study involving eight dialysis clinics in North America found that 38% of patients were judged to have 'very good deaths' following withdrawal from dialysis [7] . However, the authors noted several limitations of this tool, not least that it was not applicable to patients who did not withdraw from dialysis prior to death. The same group have developed the Dialysis Quality of Dying Apgar (QODA) for use in all end-stage renal disease (ESRD) patients, although there is no published experience using this tool to date [8] , and so, there remains no established or validated method for measuring the quality of EOL care in the ESRD population.
The aim of the study was to obtain a clinical perspective on the quality of EOL care provided to patients with advanced kidney disease using a practical and easy to use proforma that was completed at the time of death by a member of the clinical team concerned.
Materials and methods
We designed a one-page proforma (supplementary data) to collect data on various aspects of EOL care, including patient demographics, details of advance care planning and information relating to actual care delivered during the EOL period. This proforma was used to collect data relating to all deaths of patients on dialysis and patients dying on specialist renal wards over a predefined 8-week period. The 12 centres in London and South-East England who participate in the pan-Thames renal audit group were invited to take part. The proforma was completed at the time of death by senior renal or dialysis nurses or senior medical staff (registrar or consultant grade) and returned to a central unit for analysis at the end of the 8-week period.
Statistical analysis was conducted using Graphpad Prism (Graphpad Software, San Diego, CA). Comparison between groups was by Fisher's exact test.
Results

Data collection
Ten of the 12 invited centres returned completed proformas for deaths occurring over the 8-week period. About 49% of the returned questionnaires were completed by senior medical staff (renal registrar or consultant grade), 49% by senior renal or dialysis nurses and 2% were completed by both medical and nursing staff. To the best of our knowledge, all deaths during the 8-week study period have been included. The number of deaths per unit is approximately in proportion for the prevalent ESRD population for each unit as recorded by the UK Renal Registry (data not shown).
Demographics
In total, 138 deaths (78 male) were recorded from these 10 centres. The mean age at death was 68 years (range 27-92). About 64% of patients were Caucasian, 17% Afro-Caribbean, 11% south-Asian and the remainder of other or unknown ethnicity ( Table 1) .
Mode of renal replacement therapy
The vast majority (83%) were receiving maintenance haemodialysis prior to their terminal presentation (it may subsequently have been withdrawn during the palliative care phase). A small number of patients were receiving peritoneal dialysis (eight patients) and six patients had a renal allograft. The remaining 10 patients had advanced renal disease and did not receive renal replacement therapy (RRT) during their illness. This group included those patients who had planned conservative care and those who 'crash-landed' in a terminal presentation. As the numbers are small, we have not analysed outcomes for the planned conservative care patients separately.
Place of death
Sixty-nine per cent of deaths occurred during an in-patient hospital admission. About 23% occurred at home, 6% in a hospice and 1% in a nursing home. One death occurred during an out-patient dialysis attendance. The preferred place of death was known for 29 patients. Of these patients, over three quarters (79%) were cared for in their chosen location at the time of death. About 52% of patients for whom a stated preference was known wanted to die in hospital, the remainder wanting to die in their home or in a hospice. Thirty-two deaths occurred at home; the majority (91%) of these were 'sudden and unexpected'.
Hospital deaths
In total, 94 deaths (69%) occurred during an in-patient hospital admission. Table 2 shows the quality of End of Life (EOL) management in these patients. The mean length of time between admission and death was 19 days, although it should be noted that a significant number of deaths occurred within 48 h of admission or after 1 month of admission (range 0-99 days) (Figure 1 ). Dialysis was discontinued in 40% of the 83 patients who were on dialysis at the time of admission to hospital. The average time until death after discontinuation of dialysis was 5.4 days (range 0-20 days). Only 28% of patients who died in hospital had discussed EOL issues with their medical team in the year prior to death. We went on to examine these hospital deaths in more detail, as it is in this group of patients that there is the greatest potential to improve current practice given their continuous contact with health care providers. In addition, the majority of non-hospital deaths were sudden deaths at home with minimal opportunity to alter management or occurred in hospices where we assume EOL care was optimal.
Mangement of deaths in hospital. As shown in Table 2 , only 28% of patients or families had recorded discussions round the likelihood of death and its management in the preceding year. Symptoms were recorded as being well controlled in 52%, though in 22% there appeared to be no mention in the notes so the question was completed as 'unsure'. Care was documented as changing from active to palliative in 45%, with the palliative care team being involved in 34%. The final question on the proforma was 'In your opinion, was this a good quality death' with a footnote giving the definition in 'EOL Care in Advanced Kidney Disease: a framework for implementation' [5] . Only 48% of deaths were recorded as good quality.
Unexpected and expected deaths in hospital. Thirty-six per cent of all in-patient deaths were considered 'unexpected' at the time of last admission to hospital. Recognizing that a patient is at the EOL is a key to enabling a good quality death. We therefore compared standards of management in patients whose death was expected or unexpected at the time of admission (Table 3 ). Most quality markers of EOL management were less likely to be achieved in those patients whose death was unexpected. Of the expected deaths, 91% had a Do Not Attempt Resuscitation Order (DNAR) in place, 67% had changed to a palliative care approach and 44% used the Liverpool Care Pathway (LCP) compared with 23, 18 and 13%, respectively, in the unexpected group. Most strikingly, only 35% patients or families in the unexpected group had been told that death was imminent. The percentage of patients having a 'good quality death' as judged by the person completing the form was not high in either group but was lower in the unexpected group at 32% compared with 56% in the expected group.
Ethnicity
Since cultural and religious practices may influence decisions relating to EOL care, we examined the effects of ethnicity on various aspects of management, shown in Table 4 . As numbers were small for different ethnic groups, we compared Caucasian to non-Caucasian patients and included both in-hospital deaths and those that occurred in the community (home, hospice or nursing home). A lower percentage of non-Caucasian patients had their management recorded as being changed from active to palliative care; associated with this was a lower use of 'Do Not Resuscitate' orders, fewer patients having dialysis discontinued prior to death and lower use of the LCP. Interestingly, though, symptom control and a 'good quality death' were equally achieved in the two groups.
Variation between renal centres
Between 4 and 27 deaths were recorded from each of the 10 centres. Numbers are therefore small, so it is not possible to make accurate comparisons between the different centres. There was, however, considerable variation. As shown in Figure 2 , for example, care was recorded as changing from active to palliative in 18-100% of deaths occurring in individual centres.
Discussion
This study by the pan-Thames renal audit group is the first documented attempt to audit EOL management in patients with advanced kidney disease. The study was limited to patients receiving RRT and patients dying as in-patients on specialist renal wards. Patients dying in the community with CKD 5 and not on dialysis, or with a renal transplant, were not included. In this study, we have shown that by using a simple onepage document completed at the time of death, many aspects relating to the quality of EOL care can be measured and quantified. While some of the information gathered remains subjective to a degree (such as judgements relating to inappropriate prolongation of or overall 'quality' of death) much of it can be used to objectively describe the quality of EOL care and to establish if its provision is in keeping with the wishes of patients and their families, and if the recommendations of recently published national documents are being implemented.
Renal palliative care literature and guidelines suggest that the principal elements of good EOL care for the patient with advanced kidney disease include advance care planning to establish agreed level of care and preferred place of care, appropriate change of emphasis from active to palliative care including potential withdrawal of dialysis, continuing discussions with patient and family and symptom control at EOL [9] . Our results suggest that many of these elements are under-achieved, particularly in patients dying in hospital. Of these patients, for example, only 28% had discussed their EOL care with medical or nursing staff in the year before death, and only 64% patients/families had a recorded discussion about dying during their final admission. At the time of death, only 52% were recorded as having good symptom control and 30% were on the LCP, despite the recommendation as a useful tool at the EOL and the availability of adapted versions that are suitable for use in the advanced kidney disease population [10] . Overall, only 48% of deaths were deemed to be of good quality by the person completing the form.
The failure to have EOL discussions is not in keeping with the findings of Davison [11] , who found that in a group of patients with advanced kidney disease, the most valued elements of EOL care were being informed about prognosis, being informed about treatment options (including withdrawal from dialysis) and being able to prepare and plan for death. In addition, a recent study in an oncology population found that, despite physicians' concerns about the possible adverse psychological impact of EOL discussions, patients who did not recall having these discussions had more aggressive medical care with a poorer quality of life in the last days of life, with no evidence to suggest that discussions resulted in emotional distress or psychiatric disorders [12] . Similarly, a recent randomized control trial found that facilitated advance care planning in an elderly population was associated with improved EOL care [13] . It is notable that the favoured time for these discussions, according to Davison's study, was at a time of serious illness or 'when the need arises', so it is striking that only 64% of our hospitalized population were told death was imminent during their final admission to hospital, and only 28% were documented to have had EOL discussions in the year prior to this admission. About 43% of these patients had dialysis discontinued before death and 45% had changed to a palliative care strategy, despite documented EOL care discussion in only 28%. Such discussions are often poorly documented, and this may account in part for these somewhat conflicting observations. However, we would expect that where any preferences were expressed or decisions made, these should have been recorded. Our findings underscore the importance of clear documentation in case records to ensure patient's wishes are recorded and shared with all involved caregivers, allowing the principles of shared decision making and informed consent to be upheld. In addition, our study did not identify those patients who were not able, or chose not, to engage in EOL discussions, which may account in part for these findings, though highlighting the importance of advance planning for EOL care before patients become too unwell or incapacitated by illness to express their informed wishes. Twenty-three per cent of deaths in our study occurred at home, which is in slightly above the national average (19%) for patients with terminal illnesses in England [14] . However, the vast majority of home deaths in our study were 'sudden' or unexpected and are thus not reflective of a 'terminal' population. Studies suggest that the majority of people with terminal illnesses would prefer to die at home [15] , and Davison found that only one quarter of patients with advanced kidney disease wanted to die in hospital [11] . As such, our figures may well reflect a failure to meet our patients' preferences. Of concern, however, is that we do not know our patients' preferences-the favoured place of death was not known for almost 80% of patients in this study, again reflecting a failure to discuss patients' EOL care and provide the opportunity for advance planning.
Patients with renal disease have a significant complex symptom burden requiring careful management and arguably would benefit from the involvement of specialist palliative care services. Findings of a recent survey suggest that the majority of palliative care services in the UK now accept ESRD patients but that limited numbers are referred [16] , in keeping with our observation that only 34% patients were referred to specialist palliative care. It may be suggested that renal teams are increasingly able to provide palliative care for their patients and that this may account for a lower than expected referral rate to specialist services. Indeed, continuing care delivered by a familiar team with whom relationships have been developed over long periods of time may be preferable to patients. However, our data shows that even fewer patients (30%) were managed using the LCP, suggesting that their terminal care and symptom management may not be optimal and a need for increased awareness of the adapted LCP for patients with renal disease.
Over a third of in-patient deaths were considered as unexpected at the time of their final admission to hospital by their health care team, despite the fact that many were elderly, were on dialysis, had significant co-morbidities and died, on average, only 13 days later. This suggests that there were often unrealistic expectations regarding outcomes of treatment and failure to recognize the deteriorating trajectory of the patient. Unexpected death was associated with more failed attempts at resuscitation, lower use of palliative care strategies, poorer symptom control and overall poorer quality of death. Improving recognition of the EOL phase should result in improved quality of care. The first RPA guidelines were published over a decade ago and since then many methods of identifying those patients who are approaching the EOL have been described, including 'the surprise question' [17] , the Gold Service Framework prognostic indicators [18] and 'Cause for Concern' registers. Despite this, however, our observations suggest that there remains an unmet need for improved education in the geriatric and palliative aspects of care in nephrology. The explicit inclusion of these strategies as core elements of training curricula and as local and national audit criteria may improve the quality of EOL care for those with advanced kidney disease. Although the recent development of a national strategy for EOL care in the UK is encouraging, it is notable and disappointing that the recent National Institute for Health and Clinical Excellence (NICE) Quality Standards for patients with chronic kidney disease do not include a standard for EOL care [19] .
A third of the patients were from various ethnic minorities; this is not surprising given the large number of different ethnic communities in London and the higher prevalence of end-stage kidney disease in non-Caucasians. The lack of access to, and uptake of, palliative care services by some ethnic minority groups was established >15 years ago [20] and more recent evidence suggests that this disparity may be maintained in some groups across the UK [21, 22] . We therefore examined the effects of ethnicity on the quality of EOL care in our population. While their families were more likely to informed of their prognosis and to be present at the time of death, we observed a trend that patients from ethnic minorities were less likely to withdraw from dialysis and less likely to move to a palliative care pathway (including use of the LCP) prior to death. This may reflect language and actual or perceived cultural barriers to EOL discussions or changing from active to palliative care. The challenge of providing a comprehensive, culturally appropriate palliative care service and the need for ongoing research to establish the EOL needs of different populations, is well recognized.
Our study has several limitations. The use of a questionnaire-based method for data collection has obvious constraints; it is dependent on the required information being recorded in the notes and on a subjective judgement by the person completing the form. We noted a high degree of variation between individual renal units in some domains of the questionnaire, such as the proportion of patients changed to a palliative care aim shown in Figure 2 . Numbers were too small to allow comparison between units. Areas of particularly outstanding or poor care may not have been detected, therefore, as a result of our grouped analysis.
The greatest challenge presented by this study is defining what constitutes 'a good quality' death. The proforma included a footnote giving the definition used in the UK DOH document. However, this is arguably a highly subjective definition and issues relating to inappropriate prolongation and overall quality of death are clearly difficult to interrogate in detail using a closed question proformabased method (though it is notable that only a minority of respondents chose 'unsure' for any given domain on the questionnaire). In future cycles of this audit, it would be desirable to clarify some of the terminology used on the questionnaire and to train the involved staff in the interpretation and completion of the proforma.
That the proformas were completed by nursing and medical staff directly involved in patient care may have affected the objectivity of our results, and this is likely to be an inherent problem of many studies in this area. The VOICES (Views Of Informal Carers: Evaluation of Services) questionnaire (part of the PROMOTE project; The Project to impROve Management Of TErminal illness [23] ) was identified as a useful tool to be completed retrospectively by bereaved relatives or carers to evaluate the quality of care provided to patients at the EOL, and the use of such a questionnaire in future work may act to balance potential subjectivity on the part of health care providers in our study. In addition, PROMOTE identified the Palliative care Outcome Scale (POS), a prospective questionnaire used to evaluate the needs, problems and outcomes of patients, as a tool that has been used successfully in both specialist and non-specialist settings and may address some of the issues relating to retrospective data collection in our study. These questionnaires, along with the aforementioned DDQOD and QODA tools, may be used as alternative methods to evaluate EOL care and to validate the use of our questionnaire in future studies. The POS and VOICES questionnaires are not, however, designed to explore the specific needs of an ESRD population, and so important aspects of care may not be interrogated; the limitations of DDQOD and QODA have already been discussed.
Despite its limitations, our experience from conducting this study shows that it is possible to measure many important outcomes relating to quality of EOL care using a simple one-page document, completed at the time of death. Our findings suggest that many aspects of EOL care are currently under-achieved in our region, despite longstanding guidelines in this area and a widespread recognition of an increasingly aged population with advance renal disease. In part, this is due to failure to recognize the dying patient, resulting in missed opportunities for informed advance care planning and a lack of appropriate symptom control for such patients. Our observations clearly demonstrate the ongoing need for improved education of health care professionals, particularly in the detection of the deteriorating patient, the value of advance care planning and the utility of tools such as the LCP. Furthermore, the development of a health care environment where care is fully patient-centred and enabling a good quality death is perceived as a good outcome is necessary if these strategies are to succeed [24] . It is hoped that this and future work, including the completion of the audit 'cycle' once the UK DOH national strategy has had an opportunity to be embedded in practice, will raise awareness of the need for improvement, while providing a means to further define and audit the standards that we should aim to achieve.
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